Integra LifeSciences Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Integra LifeSciences Holdings Stock Forecast and Price Target
If Integra LifeSciences Holdings's stock price reached the average yearlong target of $43.50 given by four well-known analysts in recent months, there would be a potential upside of approximately 20.1% from its last closing price in March, 2024. This potential increase is based on a high estimate of $57.00 and a low estimate of $37.00. If you are looking to invest in the stock, it's important to research and compare different companies.
20.10% Upside
Integra LifeSciences Holdings Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Integra LifeSciences Holdings's Price has decreased from $46.77 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $65.86 – an increase of 100.00%. For the next seven years, experts predict that Integra LifeSciences Holdings's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ABBV Stock Forecast | AbbVie | Outperform |
9
|
$179.63 | Buy/Sell | $178.42 | 0.21% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.37 | Buy/Sell | $32.87 | 10.82% |
SIE Stock Forecast | Siemens | Outperform |
10
|
180.62€ | Buy/Sell | 178.14€ | 7.96% |
SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$355.59 | Buy/Sell | $353.16 | 1.38% |
ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$378.90 | Buy/Sell | $408.45 | 11.38% |
Integra LifeSciences Holdings Revenue Forecast for 2023 - 2025 - 2030
Integra LifeSciences Holdings's Revenue has grown In the last three years, rising from $1.37B to $1.54B – a growth of 12.37%. In the next year, analysts believe that Revenue will reach $1.62B – an increase of 4.87%. For the next eight years, experts predict that Integra LifeSciences Holdings's Revenue will grow at a rate of 22.67%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MDT Stock Forecast | Medtronic | Outperform |
11
|
$85.50 | Buy/Sell | $92.47 | 11.11% |
BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$66.12 | Buy/Sell | $70.14 | 8.89% |
EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$90.83 | Buy/Sell | $91.18 | 1.84% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MMM Stock Forecast | 3M | Hold |
10
|
$94.05 | Buy/Sell | $109.39 | 15.90% |
COLO B Stock Forecast | Coloplast A/S | Hold |
18
|
kr965.20 | Buy/Sell | kr812.28 | -6.76% |
RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$189.75 | Buy/Sell | $201.32 | 8.04% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ZBH Stock Forecast | Zimmer Biomet Holdings | Hold |
15
|
$128.04 | Buy/Sell | $132.52 | 5.44% |
WST Stock Forecast | West Pharmaceutical Services | Outperform |
18
|
$357.52 | Buy/Sell | $380.80 | 6.29% |
STE Stock Forecast | STERIS | Outperform |
13
|
$233.84 | Buy/Sell | $238.33 | 4.77% |
Integra LifeSciences Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Integra LifeSciences Holdings has seen a decline in its EBITDA, from $335.84M to $123.90M – a 63.11% decrease. In the next year, analysts predict that EBITDA will jump to $407.34M – up 228.77% from the current level. Looking ahead to eight years, experts forecast that EBITDA will grow by 320.74%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
COO Stock Forecast | The Cooper Companies | Outperform |
13
|
$101.44 | Buy/Sell | $391.40 | 4.99% |
PHIA Stock Forecast | Koninklijke Philips N.V. | Hold |
18
|
19.63€ | Buy/Sell | 19.42€ | -0.66% |
HOLX Stock Forecast | Hologic | Outperform |
8
|
$76.33 | Buy/Sell | $81.06 | 7.56% |
Integra LifeSciences Holdings EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Integra LifeSciences Holdings's EBIT has decreased by 49.26%, from $219.81M to $111.53M. Analysts predict that Integra LifeSciences Holdings's EBIT will increase in the upcoming year, reaching $361.56M. This would represent an increase of 224.18%. Over the next eight years, experts predict that Integra LifeSciences Holdings's EBIT will grow at a rate of 331.72%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ABMD Stock Forecast | Abiomed | - |
16
|
$377.79 | Buy/Sell | $380.00 | -88.33% |
SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£10.91 | Buy/Sell | £16.09 | 53.35% |
TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$227.11 | Buy/Sell | $263.46 | 16.68% |
Integra LifeSciences Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Integra LifeSciences Holdings's EPS has decreased from $2.45 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $3.45 – an increase of 100.00%. For the next seven years, experts predict that Integra LifeSciences Holdings's EPS will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
GMED Stock Forecast | Globus Medical | Outperform |
16
|
$55.10 | Buy/Sell | $64.58 | 12.52% |
XRAY Stock Forecast | DENTSPLY SIRONA | Outperform |
17
|
$33.87 | Buy/Sell | $36.00 | 10.72% |
CTEC Stock Forecast | ConvaTec Group PLC | Outperform |
16
|
£2.81 | Buy/Sell | £3.43 | 33.81% |